All Articles

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

Ambow Education launches HybriU ProjectHub, an AI platform aiming to unify a chaotic landscape of apps. But can it break through in a market dominated by titans?

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

Lotus Tech's new sustainability report isn't just about green goals; it's a strategic play for investor trust with zero recalls and ambitious carbon targets.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

Century 21 Canada reports a stunning 39% growth surge in Quebec. Is this a fluke, or a new blueprint for challenging market leaders with tech and local focus?

As Canada's new AI Minister prepares to address Toronto's elite, he carries a multi-billion-dollar plan. But can policy bridge the gap from research to reality?

With a new CEO known for scaling data-driven platforms, OWL AI is moving beyond officiating to become the foundational intelligence layer for live sports.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.